Cite
MLA Citation
Ian E. James et al.. “A First‐in‐Human Clinical Study With TRV734, an Orally Bioavailable G‐Protein–Biased Ligand at the μ‐Opioid Receptor.” Clinical pharmacology in drug development, vol. 9, no. 2, 2020, pp. 256–266. http://access.bl.uk/ark:/81055/vdc_100099990432.0x000009